ROOHA (HANGZHOU) TECHNOLOGY CO.,LTD
|
Fmoc-AEEA,166108-71-0
Fmoc-AEEA is a key intermediate in the synthesis of the anti-HIV drug elvitegravir and the diabetes therapeutic semaglutide. This chemically modified PEG and its homologues can also be applied in pharmaceutical research, for example, to modify protein drugs, peptide compounds, liposomes, and small-molecule drugs via coupling reactions. |
Send Inquiry
|